Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-18T01:58:58.205Z Has data issue: false hasContentIssue false

Risk of fibromyalgia in patients with primary muscle tension dysphonia: a possible local manifestation of a musculoskeletal systemic disorder

Published online by Cambridge University Press:  07 July 2023

Abdul-Latif Hamdan
Affiliation:
Otolaryngology Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon
Elie Alam
Affiliation:
Otolaryngology Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon
Patrick A R Feghali
Affiliation:
Otolaryngology Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon
Charbel Fadel
Affiliation:
Otolaryngology Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon
Christopher Jabbour
Affiliation:
Otolaryngology Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon
Anthony Ghanem*
Affiliation:
Otolaryngology Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon
*
Corresponding author: Anthony Ghanem; Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Objective

To investigate the risk of fibromyalgia in patients with primary muscle tension dysphonia.

Methods

A retrospective review was conducted of patients with primary muscle tension dysphonia, diagnosed based on history of dysphonia with evidence of laryngeal muscle tension on examination. Fibromyalgia was assessed using the Fibromyalgia Rapid Screening Tool (‘FiRST’).

Results

Fifty patients were enrolled: 25 with primary muscle tension dysphonia (study group) and 25 matched controls. The mean age of the study group was 50.7 ± 15.2 years versus 49.5 ± 18.6 years for the controls, with a male to female ratio of 3:2 for both groups. Fifty-six per cent tested positive for fibromyalgia in the study group versus 4 per cent in the controls (p < 0.001). The mean Voice Handicap Index 10 score in the study group was significantly higher for those who screened positive for fibromyalgia compared to those who screened negative. There was a positive, strong point-biserial correlation between Fibromyalgia Rapid Screening Tool and Voice Handicap Index 10 scores (r = 0.39; p = 0.09).

Conclusion

These results suggest that fibromyalgia is a significant co-morbid condition in primary muscle tension dysphonia.

Type
Main Article
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Introduction

Muscle tension dysphonia is a phonatory disorder characterised by an increase in laryngeal muscle tension. Patients invariably present with dysphonia, voice fatigue, globus sensation, throat clearing and dryness in the mouth.Reference Altman, Atkinson and Lazarus1 The diagnosis of muscle tension dysphonia hinges on a thorough examination of the neck and laryngopharyngeal complex. A high positioned larynx, referred to as laryngeal rise, narrowing of the thyrohyoid space, and tension or stiffness in the paralaryngeal muscles, are common findings in affected patients. The most frequent sign on flexible nasopharyngoscopy is supraglottic constriction during phonation. Different laryngeal muscle tension patterns have been described by various authors.Reference Koufman and Blalock2Reference Morrison, Nichol and Rammage4 Based on a review by Garaycochea et al., medialisation of the false vocal folds and anteroposterior compression of the larynx are the most significant laryngeal findings, associated with alteration in mean subglottic pressure.Reference Garaycochea, Navarrete, Del Río and Fernández5 In the absence of a structural or neurological disorder, muscle tension dysphonia is referred to as primary muscle tension dysphonia. In the presence of a structural abnormality such as vocal fold mass, scarring and atrophy, or a neurological disorder such as vocal fold paresis or paralysis, muscle tension dysphonia is considered a secondary phonatory disorder.Reference Altman, Atkinson and Lazarus1

There are numerous studies on the pathophysiology of muscle tension dysphonia, with the consensus that high vocal loading and phonatory stress are the main precipitating factors. Co-morbid conditions associated with muscle tension dysphonia include personality disorders, mental illnesses, reflux disease and hormonal imbalance, among many others.Reference Koufman, Amin and Panetti6Reference Vertigan, Kapela and Gibson11 Fibromyalgia has scarcely been reported as a co-morbid condition in muscle tension dysphonia, although patients with muscle tension dysphonia suffer from paralaryngeal muscle pain and stiffness similar to that reported by patients with fibromyalgia but in peripheral muscles. In 2015, Craig et al. reported fibromyalgia and chronic pain in 8 per cent and 5.9 per cent of patients with muscle tension dysphonia, respectively.Reference Craig, Tomlinson, Stevens, Kotagal, Fornadley and Jacobson12 Similarly, in 2018, McGarey et al., in their study on co-morbid dysphagia and dyspnoea in muscle tension dysphonia patients, reported fibromyalgia as a co-morbid condition in 5.3 per cent of the cases.Reference McGarey, Barone, Freeman and Daniero13 In both studies, the history of fibromyalgia was retrieved from the patients’ medical history database.

This investigation aimed to examine the risk of fibromyalgia in patients with primary muscle tension dysphonia. The impetus for this study is the growing evidence in the literature suggesting that muscle tension dysphonia is a systemic disorder amenable to physical therapy.Reference Craig, Tomlinson, Stevens, Kotagal, Fornadley and Jacobson12 Neuroimaging studies have shown the presence of alteration in the central laryngeal motor and sensory control areas related to phonation, findings suggestive of a central neurological disorder that also favour a systemic approach to the diagnosis and treatment of muscle tension dysphonia.Reference Kryshtopava, Van Lierde, Meerschman, D'haeseleer, Vandemaele and Vingerhoets14

Materials and methods

After obtaining institution review board approval, the medical records of all patients presenting to the voice and swallowing unit at a tertiary referral centre between June 2022 and November 2022, who were diagnosed with primary muscle tension dysphonia, were reviewed. The diagnosis of primary muscle tension dysphonia was based on a history of dysphonia, with evidence of laryngeal muscle tension on laryngeal examination, in the absence of a structural or neurological disorder. The risk of fibromyalgia was assessed by reviewing the Fibromyalgia Rapid Screening Tool (‘FiRST’) score, with a score above 5 considered positiveReference Perrot, Bouhassira and Fermanian15 (refer to Appendix 1 for the detailed Fibromyalgia Rapid Screening Tool questionnaire). The Fibromyalgia Rapid Screening Tool is a six-question validated screening questionnaire; it has a sensitivity of 90.5 per cent, a specificity of 85.7 per cent, a positive predictive value of 89.5 per cent and a negative predictive value of 87.5 per cent, for scores of 5 or more.Reference Perrot, Bouhassira and Fermanian15

The demographic data collected included age, gender, history of smoking and history of professional voice use. The impact of dysphonia on quality of life was also analysed using the Voice Handicap Index 10 (VHI-10), as described by Rosen et al.Reference Rosen, Lee, Osborne, Zullo and Murry16

A control group with no history of dysphonia was matched to patients in terms of age, gender, professional voice use and smoking status.

Statistical analysis

The Statistical Package for Social Sciences (SPSS) software, version 24.0, was used for data analysis. Continuous variables were analysed using descriptive statistics (means and standard deviations). The chi-square test was used to determine the association between categorical variables. Statistical significance was set at a p-value of less than 0.05.

Results

Demographic data

A total of 50 patients were enrolled in this study: 25 patients diagnosed with primary muscle tension dysphonia were referred to as the ‘study group’, and 25 healthy subjects with no history of dysphonia were referred to as the ‘control group’. The mean age of the study group was 50.7 ± 15.2 years and that of the control group was 49.5 ± 18.6 years. The male to female ratio was 3:2 for both groups. In each group, 44 per cent were smokers and 4 per cent had a history of professional voice use (Table 1).

Table 1. Demographics of study sample

*n = 25; n = 25. SD = standard deviation; VHI = Voice Handicap Index

Screening and Voice Handicap Index scores

Fifty-six per cent of the study group tested positive on the Fibromyalgia Rapid Screening Tool as compared to only 4 per cent in the control group. The difference between the two groups was statistically significant (p < 0.001) (Table 2).

Table 2. Characteristics of study subjects

Moreover, within the study group, the mean Voice Handicap Index 10 score was significantly higher in those who screened positive for fibromyalgia (22.86 ± 11.24) in comparison to those who screened negative (13.91 ± 11.23), with a one-tailed p-value of 0.045. There was a positive and strong point-biserial correlation between the Fibromyalgia Rapid Screening Tool score and the Voice Handicap Index 10 score (r = 0.39), but this did not reach statistical significance (p = 0.09).

Discussion

Fibromyalgia is a syndrome characterised by multi-focal pain and stiffness, the severity of which varies with the patients’ morbidity and the disease course. Other symptoms include body fatigue, cognitive dysfunction and sleep disturbance.Reference Kalichman17Reference Borchers and Gershwin21 Fibromyalgia has been described in association with infectious, inflammatory and autoimmune diseases, with no clear consensus on its pathophysiology. The clinical presentation is often misleading, with no rigid criteria for diagnosis or treatment. A main diagnostic feature set by the American College of Rheumatology is body pain, in addition to increased sensitivity to pressure at specific points in the body.Reference Wolfe, Clauw, Fitzcharles, Goldenberg, Katz and Mease22 Nevertheless, fibromyalgia is often considered a mysterious syndrome as it does not fit the traditional definition of a disease.

In this investigation, 56 per cent of patients with primary muscle tension dysphonia screened positive for fibromyalgia using the Fibromyalgia Rapid Screening Tool. This percentage is higher than that reported by previous studies, probably because a fibromyalgia screening questionnaire was used, rather than a review of patients’ medical history. The results of this study indicate a strong correlation between Fibromyalgia Rapid Screening Tool scores and Voice Handicap Index 10 scores, suggesting that patients with dysphonia and systemic complaints such as pain and fatigue had a worse quality of life than those with dysphonia alone.

The findings of this investigation are not surprising given the central aetiology of fibromyalgia.Reference Lachaine, Beauchemin and Landry23Reference Jones, Atzeni, Beasley, Flüß, Sarzi-Puttini and Macfarlane26 Fibromyalgia is no longer referred to as a peripheral inflammatory disorder, ‘fibrositis’, but rather a disorder of central origin. Neuroimaging studies of affected patients have shown alterations in the descending inhibitory pain pathways and abnormal function in the ascending pathways that facilitate pain. As a result, there is a decrease in the pain threshold, resulting in hyperalgesia and tenderness.Reference Nijs, Malfliet, Ickmans, Baert and Meeus27Reference Bradley, Alberts, Alarcon, Alexander, Mountz and Weigent31 To that end, fibromyalgia is considered by many to be a ‘central sensitivity syndrome’.Reference Inanici and Yunus32 Central sensitivity syndrome is an umbrella term that includes myofascial pain, temporomandibular joint dysfunction and many other musculoskeletal pain disorders.Reference Theoharides, Tsilioni, Arbetman, Panagiotidou, Stewart and Gleason33 There is also growing evidence in the literature to suggest that muscle tension dysphonia can be due to a central neurological dysfunction. Kryshtopava et al. investigated the brain activity of 10 women with muscle tension dysphonia using functional magnetic resonance imaging, and showed a decrease in activity in sensory control related areas and an increase in activity in the laryngeal motor control related areas.Reference Kryshtopava, Van Lierde, Meerschman, D'haeseleer, Vandemaele and Vingerhoets14 The authors suggested that muscle tension dysphonia can be a disease of abnormal sensory processing that leads to alterations in motor control and descending motor cortical signals, resulting in excessive laryngeal tension and dysphonia.Reference Kryshtopava, Van Lierde, Meerschman, D'haeseleer, Vandemaele and Vingerhoets14

  • Muscle tension dysphonia is a phonatory disorder characterised by increased laryngeal muscle tension, with dysphonia, voice fatigue, globus sensation, throat clearing and mouth dryness

  • Studies on the pathophysiology of muscle tension dysphonia agree that high vocal loading and phonatory stress are the main precipitating factors

  • Co-morbid conditions associated with muscle tension dysphonia include personality disorders, mental illnesses, reflux disease and hormonal imbalance

  • Fibromyalgia has been scarcely reported as a co-morbid condition in patients with muscle tension dysphonia

  • This investigation indicated that patients with primary muscle tension dysphonia are at high risk of having fibromyalgia

  • Primary muscle tension dysphonia may have a systemic nature, highlighting the need for a systemic approach when managing affected patients

Another factor that can explain the high risk of fibromyalgia in patients with muscle tension dysphonia is the significant overlap in the demographic characteristics and medical history of patients with muscle tension dysphonia and fibromyalgia. Both muscle tension dysphonia and fibromyalgia are more common in women in middle age, with a female-to-male ratio of 2:1 being reported in fibromyalgia cases.Reference Bair and Krebs34 Mental illnesses and personality disorders are also common in a large percentage of patients. A common personality trait in muscle tension dysphonia patients is introversion, and a significant subset of affected patients exhibit high levels of anxiety and depression. This has led many investigators to consider ‘personality disorders’ as a characteristic diagnostic feature of muscle tension dysphonia that needs to be addressed in the management strategy.Reference Gerritsma7,Reference McGrory, Tasko, Bless, Heisey and Ford8,Reference Roy, Bless and Heisey35 Similar to muscle tension dysphonia, fibromyalgia is also associated with mental illnesses.Reference González, Elorza and Failde36 Although there is no clear consensus on the aetiology of fibromyalgia, what is indisputable is its strong association with affective disorders; this has led many authors to attribute the musculoskeletal symptoms in affected patients to stress, anxiety and depression.Reference Hudson and Pope37Reference Van Houdenhove and Luyten39

This study highlights a strong link between fibromyalgia and muscle tension dysphonia, an interesting fact that warrants further investigation. Nevertheless, this study has its limitations. One limitation is the small number of subjects in our cohort. Another limitation is the lack of physical examination or objective testing such as inflammatory markers to confirm the diagnosis of fibromyalgia.

Conclusion

The results of this investigation indicate that patients with primary muscle tension dysphonia are at a high risk of having fibromyalgia. A large percentage of affected patients exhibit pain and fatigue in other sites of the body aside from the laryngo-pharyngeal complex. These findings allude to the possible systemic nature of primary muscle tension dysphonia, and hence the need for a systemic approach in the management of affected patients. Similar to fibromyalgia patients who benefit from myofascial release to reduce pain, and connective tissue massage to improve depression,Reference Yuan, Matsutani and Marques40 muscle tension dysphonia patients may also benefit from adjunctive treatment modalities that include conventional laryngeal manual therapy and circumlaryngeal massage.

Competing interests

None declared

Appendix A – Fibromyalgia Rapid Screening Tool

You have been suffering from joint, muscle or tendon pain for the past 3 months at least.

Please fill in this questionnaire by answering either yes or no (only 1 answer: YES or NO) to each of the following statements. Put a cross in the box that corresponds to your answer.

Footnotes

Anthony Ghanem takes responsibility for the integrity of the content of the paper

References

Altman, KW, Atkinson, C, Lazarus, C. Current and emerging concepts in muscle tension dysphonia: a 30-month review. J Voice 2005;19:261–7CrossRefGoogle ScholarPubMed
Koufman, JA, Blalock, PD. Functional voice disorders. Otolaryngol Clin North Am 1991;24:1059–73CrossRefGoogle ScholarPubMed
Van Lawrence, L. Suggested criteria for fibre-optic diagnosis of vocal hyperfunction. Care of the Professional Voice Symposium. London: British Voice Association, 1987Google Scholar
Morrison, MD, Nichol, H, Rammage, LA. Diagnostic criteria in functional dysphonia. Laryngoscope 1986;96:18CrossRefGoogle ScholarPubMed
Garaycochea, O, Navarrete, JMA, Del Río, B, Fernández, S. Muscle tension dysphonia: which laryngoscopic features can we rely on for diagnosis? J Voice 2019;33:812.e15–18CrossRefGoogle ScholarPubMed
Koufman, JA, Amin, MR, Panetti, M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123:385–8CrossRefGoogle ScholarPubMed
Gerritsma, E. An investigation into some personality characteristics of patients with psychogenic aphonia and dysphonia. Folia Phoniatr (Basel) 1991;43:1320CrossRefGoogle ScholarPubMed
McGrory, JJ, Tasko, SM, Bless, DM, Heisey, D, Ford, CN. Psychological correlates of functional dysphonia: an investigation using the Minnesota Multiphasic Personality Inventory. J Voice 1997;11:443–51CrossRefGoogle Scholar
Roy, N, Bless, DM. Personality traits and psychological factors in voice pathology: a foundation for future research. J Speech Lang Hear Res 2000;43:737–48CrossRefGoogle Scholar
Neuman Taylor, AJ. ABC of allergies. Asthma and allergy. BMJ 1998;316:997–9CrossRefGoogle ScholarPubMed
Vertigan, AE, Kapela, SL, Gibson, PG. Laryngeal dysfunction in severe asthma: a cross-sectional observational study. J Allergy Clin Immunol Pract 2021;9:897905CrossRefGoogle ScholarPubMed
Craig, J, Tomlinson, C, Stevens, K, Kotagal, K, Fornadley, J, Jacobson, B et al. Combining voice therapy and physical therapy: a novel approach to treating muscle tension dysphonia. J Commun Disord 2015;58:169–78CrossRefGoogle ScholarPubMed
McGarey, PO Jr, Barone, NA, Freeman, M, Daniero, JJ. Comorbid dysphagia and dyspnea in muscle tension dysphonia: a global laryngeal musculoskeletal problem. OTO Open 2018;2:2473974X18795671CrossRefGoogle ScholarPubMed
Kryshtopava, M, Van Lierde, K, Meerschman, I, D'haeseleer, E, Vandemaele, P, Vingerhoets, G et al. Brain activity during phonation in women with muscle tension dysphonia: an fMRI study. J Voice 2017;31:675–90CrossRefGoogle ScholarPubMed
Perrot, S, Bouhassira, D, Fermanian, J. Development and validation of the fibromyalgia rapid screening tool (FiRST). Pain 2010;150:250–6CrossRefGoogle ScholarPubMed
Rosen, CA, Lee, AS, Osborne, J, Zullo, T, Murry, T. Development and validation of the voice handicap index-10. Laryngoscope 2004;114:1549–56CrossRefGoogle ScholarPubMed
Kalichman, L. Association between fibromyalgia and sexual dysfunction in women. Clin Rheumatol 2009;28:365–9CrossRefGoogle ScholarPubMed
Sandıkçı, SC, Özbalkan, Z. Fatigue in rheumatic diseases. Eur J Rheumatol 2015;2:109–13CrossRefGoogle ScholarPubMed
Bennett, RM, Jones, J, Turk, DC, Russell, IJ, Matallana, L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007;8:27CrossRefGoogle Scholar
Kleinman, L, Mannix, S, Arnold, LM, Burbridge, C, Howard, K, McQuarrie, K et al. Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary. Health Qual Life Outcomes 2014;12:111CrossRefGoogle ScholarPubMed
Borchers, AT, Gershwin, ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol 2015;49:100–51CrossRefGoogle ScholarPubMed
Wolfe, F, Clauw, DJ, Fitzcharles, MA, Goldenberg, DL, Katz, RS, Mease, P et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600–10CrossRefGoogle ScholarPubMed
Lachaine, J, Beauchemin, C, Landry, P-A. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain 2010;26:284–90CrossRefGoogle ScholarPubMed
Spaeth, M, Briley, M. Fibromyalgia: a complex syndrome requiring a multidisciplinary approach. Hum Psychopharmacol 2009;24:S310CrossRefGoogle ScholarPubMed
Queiroz, LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013;17:356CrossRefGoogle ScholarPubMed
Jones, GT, Atzeni, F, Beasley, M, Flüß, E, Sarzi-Puttini, P, Macfarlane, GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol 2015;67:568–75CrossRefGoogle ScholarPubMed
Nijs, J, Malfliet, A, Ickmans, K, Baert, I, Meeus, M. Treatment of central sensitization in patients with ‘unexplained’ chronic pain: an update. Expert Opin Pharmacother 2014;15:1671–83CrossRefGoogle ScholarPubMed
Lorenz, J, Grasedyck, K, Bromm, B. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996;100:165–8CrossRefGoogle ScholarPubMed
Vaeroy, H, Helle, R, Førre, O, Kåss, E, Terenius, L. Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1988;15:1804–6Google ScholarPubMed
Xu, X-J, Dalsgaard, C-J, Wiesenfeld-Hallin, Z. Spinal substance P and N-methyl-D-aspartate receptors are coactivated in the induction of central sensitization of the nociceptive flexor reflex. Neuroscience 1992;51:641–8CrossRefGoogle ScholarPubMed
Bradley, L, Alberts, K, Alarcon, G, Alexander, M, Mountz, J, Weigent, D et al. Abnormal brain regional cerebral blood flow (rCBF) and cerebrospinal fluid (CSF) levels of substance P (SP) in patients and non-patients with fibromyalgia (FM). Arthritis Rheum 1996;39:1109–1109Google Scholar
Inanici, FF, Yunus, MB. History of fibromyalgia: past to present. Curr Pain Headache Rep 2004;8:369–78CrossRefGoogle ScholarPubMed
Theoharides, TC, Tsilioni, I, Arbetman, L, Panagiotidou, S, Stewart, JM, Gleason, RM et al. Fibromyalgia syndrome in need of effective treatments. J Pharmacol Exp Ther 2015;355:255–63CrossRefGoogle ScholarPubMed
Bair, MJ, Krebs, EE. Fibromyalgia. Ann Intern Med 2020;172:ITC3348CrossRefGoogle ScholarPubMed
Roy, N, Bless, DM, Heisey, D. Personality and voice disorders: a multitrait-multidisorder analysis. J Voice 2000;14:521–48CrossRefGoogle ScholarPubMed
González, E, Elorza, J, Failde, I. Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients. Actas Esp Psiquiatr 2010;38:295300Google ScholarPubMed
Hudson, JI, Pope, HG Jr. Fibromyalgia and psychopathology: is fibromyalgia a form of “affective spectrum disorder”? J Rheumatol Suppl 1989;19:1522Google ScholarPubMed
Clauw, DJ. Fibromyalgia: more than just a musculoskeletal disease. Am Fam Physician 1995;52:843–51, 53Google ScholarPubMed
Van Houdenhove, B, Luyten, P. Stress, depression and fibromyalgia. Acta Neurol Belg 2006;106:149–56Google ScholarPubMed
Yuan, SLK, Matsutani, LA, Marques, AP. Effectiveness of different styles of massage therapy in fibromyalgia: a systematic review and meta-analysis. Man Ther 2015;20:257–64CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Demographics of study sample

Figure 1

Table 2. Characteristics of study subjects